Background-Integrin-linked kinase (ILK) is a serine/threonine kinase that has been linked to human and experimental heart failure, but its role in the heart is not fully understood. Methods and Results-To define the role of cardiomyocyte ILK, we generated cardiac-specific ILK knockout mice using αmyosin heavy chain-driven Cre expression. Cardiac-specific ILK knockout mice spontaneously developed lethal dilated cardiomyopathy and heart failure with an early increase in apoptosis, fibrosis, and cardiac inflammation. To identify downstream effectors, we used deep sequence analysis of gene expression to compare comprehensive transcriptional profiles of cardiac-specific ILK knockout and wild-type hearts from 10-day-old mice before the development of cardiac dysfunction. Approximately 2×10 6 cDNA clones from each genotype were sequenced, corresponding to 33 274 independent transcripts. A total of 93 genes were altered, using nominal thresholds of >1.4-fold change and P<0.001. The most highly upregulated gene was osteopontin (47-fold increase; P=9.6×10 −45 ), an inflammatory chemokine implicated in heart failure pathophysiology. ILK also regulated osteopontin expression in cardiomyocytes in vitro. Importantly, blocking antibodies to osteopontin mitigated but did not fully rescue the functional decline in cardiac-specific ILK knockout mice. Conclusions-Cardiomyocyte-specific ILK deletion leads to a lethal cardiomyopathy characterized by cardiomyocyte death, fibrosis, and inflammation. Comprehensive profiling identifies ILK-dependent transcriptional effects and implicates osteopontin as a contributor to these phenotypes. (Circ Heart Fail. 2014;7:184-193.) 
T he serine/threonine kinase, integrin-linked kinase (ILK), was identified as a protein interacting with the cytoplasmic tail of β1 integrins. 1 The ternary complex of ILK, PINCH (particularly interesting Cys-His-rich protein), and parvin (IPP complex) couples integrins to the actin cytoskeleton. 2 ILK phosphorylates integrin cytoplasmic domains and multiple downstream signaling/ cytoskeletal proteins, regulating cascades of integrin-mediated signaling events. This connection to bidirectional integrin signaling raises the possibility that ILK could regulate the heart's response to biomechanical stress. Interestingly, ILK expression is increased in human cardiac hypertrophy, 3 and point mutations in ILK associated with dilated cardiomyopathy (DCM) in humans are linked to defects in both endothelial cells and cardiomyocytes in model systems. 4 Furthermore, ILK protein complexes are essential components of the cardiac mechanical stretch sensor in zebrafish. 5 These studies provide a genetic link between aberrant ILK function and cardiovascular disease and underscore the potential relevance and importance of understanding the cardiovascular roles of ILK. The current study investigates the physiological roles of ILK in cardiomyocytes through conditional deletion. Whether ILK has kinase-independent activity is controversial. 6 Ablation of ILK in the heart, 7 skeletal muscle, 8 or nervous system 9 abrogated phosphorylation of Ser473 of Akt, but knock-in mice carrying mutations in the putative PH domain (R211A) or in the autophosphorylation site (S343A or S343D) are completely normal and do not show changes in Akt or Gsk-3β phosphorylation or actin organization downstream of integrins. 10 However, knock-in of K220M, an essential amino acid for ILK kinase activity within the ATP-binding subdomain-2 of the catalytic domain, resulted in severe developmental defects in the kidney. 10 Mice with ILK deletion in both heart and skeletal muscle developed heart failure with disrupted cytoarchitecture and fibrosis, as well as decreased phosphorylation of FAK (focal adhesion kinase) and Akt, leading the authors to implicate loss of signaling via these pathways as primary contributors to the phenotypes observed. 7 However, genetic deletion of molecules in this pathway, including FAK, 11 Akt, 12, 13 PINCH1, 14 or β1-integrin itself, 15 has either no or mild cardiac phenotypes at baseline, only developing DCM after biomechanical stress such as aortic constriction. Thus, the much more severe phenotype seen with cardiac and skeletal ILK deletion suggests that other unrecognized mechanisms may be playing an important role. Although skeletal muscle appeared normal in these mice, it is difficult to exclude a potential contribution from systemic effects of subtle abnormalities.
Here, we report the generation and characterization of cardiac-specific ILK knockout (CSILK-KO) mice. CSILK-KO mice develop a dramatic and early lethal DCM and fibrosis associated with inflammation and cardiomyocyte apoptosis. To define the downstream mechanisms, we used deep sequence analysis of gene expression (DSAGE), 16 a novel nanotechnology that enables high-fidelity nucleic acid sequencing at reduced cost to sequence ≈2 million cDNA clones from CSILK-KO and control hearts at 10 days postnatally before the development of cardiac dysfunction. Interestingly, the single most upregulated transcript was osteopontin (OPN), an inflammatory chemokine previously associated with myocarditis and heart failure. 17, 18 Recent literature 19 and experiments with function-blocking antibodies suggest that OPN is an important contributor to the phenotype in CSILK-KOs. Thus, the current studies link ILK to previously unrecognized cardiac phenotypes, provide a global transcriptional profile of the effects of cardiomyocyte ILK deletion, and underscore the importance of Akt-independent effectors in these phenotypes.
Methods

Generation of Cardiomyocyte-Specific ILK KO Mice
α-Myosin heavy chain Cre (α-MHC-Cre) mice 20 were crossed with homozygous floxed ILK (ILK fl/fl ) mice 21 to generate cardiacspecific ILK knockout animals (CSILK-KO: α-MHC-Cre + ; ILK fl/fl ), and the α-MHC-Cre − littermates were used as controls (wild type: α-MHC-Cre − ; ILK fl/fl ). All mice were on a C57BL/6 background. Genotyping was performed as previously described. 21 Animals were handled in accordance with protocols approved by the Beth Israel Deaconess Medical Center Subcommittee on Research Animal Care.
Cardiac Morphological Analyses
Hearts were excised and fixed overnight in 4% paraformaldehyde. After progressive dehydration with 20% glucose, heart samples were embedded in paraffin. Eight-micrometer sections were subjected to Masson trichrome staining for fibrosis visualization. Images were collected using a Leica DM IRB microscope and a Leica camera (Leica Microsystems). Quantification of collagen deposition in cross-sections was performed with Photoshop.
Immunohistochemistry and Immunofluorescence Staining
Immunofluorescence staining of cardiac cryosections from CSILK-KO and control mice (4 each) was performed using the VECTASTAIN ABC Kit (Vector Laboratory) as described 22 with DAPI (4',6-diamidino-2-phenylindole; Invitrogen) nuclear counterstaining. The following primary antibodies were used: anti-α-actinin (1:400; Sigma-Aldrich), anti-ILK (1:1000; Upstate), and anti-CD45 (1:100; BD Pharmingen).
Echocardiography
Echocardiography was performed on unanesthetized mice using a 13L high-frequency linear (10 MHz) transducer (VingMed 5; GE Medical Services) with depth set at 1 cm and 236 frames per second for 2-dimensional images. M-mode images used for measurements were taken at the midpapillary muscle level.
Immunoblotting
Cardiomyocyte protein extracts were prepared as described. 23 Protein from 10-to 21-day-old mouse hearts was obtained after atria were removed. After concentration determination by the Bradford method (Bio-Rad), proteins (50 µg) were separated by SDS-PAGE on 4% to 20% gels and transferred to nitrocellulose membranes (Bio-Rad) by semidry transfer. Blots were incubated with anti-ILK (1:1000; Upstate), anti-OPN (1:1000; Santa Cruz), anti-phospho-Ser-473-Akt (1:1000; serine 473; Cell Signaling), and anti-GAPDH (1:4000, Cell Signaling) overnight at 4°C and subsequently incubated with horseradish peroxidase-conjugated secondary antibody (1:2000; Cell signaling) and detected by chemiluminescence (Cell Signaling).
RNAi
Cells were transfected with small interfering RNA (siRNA) duplexes (Applied Biosystems) at 10 nmol/L using Lipofectamine RNAimax transfection reagent (Invitrogen). siRNA target ILK sequences (5′ to 3′) were as follows: sense-GUAGUGUAAUGAUCGAUGAtt and antisense-UCAUCGAUCAUUACACUACgg (s139497). Silencer Select negative control siRNA was purchased from Applied Biosystems. siRNA transfections were performed in 6-well plates and harvested 48 hours later.
Quantitative Reverse Transcription Polymerase Chain Reaction
Total RNA was isolated from cardiac ventricles using TRIzol (Invitrogen) per the manufacturer's recommendations. RNA concentration was determined with a spectrophotometer, and 2 μg was used to prepare cDNA (Applied Biosystems). mRNA quantification was performed for validation by quantitative reverse transcription polymerase chain reaction (QRT-PCR) relative to GAPDH using the ΔΔCT method as described. 24 Primer sequences are listed in the Data Supplement.
TUNEL Staining
TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining was performed with the ApopTag Plus Fluorescein In Situ Aopotosis Detection Kit (Millipore) according to the manufacturer's recommendations. α-Actinin (1:400; Sigma) was used to identify cardiomyocytes (red), and nuclei were counterstained with DAPI (Invitrogen). TUNEL-positive cardiomyocytes were counted in 10 low-power fields from 3 cardiac cryosections of CSILK-KO and controls. More than 1000 nuclei were counted with National Institutes of Health (NIH) ImageJ.
Deep Sequence Analysis of Gene Expression
Total RNA was prepared from 5 hearts from male mice of each genotype (α-MHC-Cre + /ILK flox/flox and α-MHC-Cre − /ILK flox/flox ) using Trizol (Invitrogen). RNA from each genotype was pooled in equal proportion to provide 10 µg of total RNA for the generation of cDNA libraries. 25 
Antibody Treatment
Newborn CSILK-KO pups were followed by echocardiography until their fractional shortening was reduced to ≈40% and then treated with a neutralizing goal polyclonal OPN IgG (R&D Systems) or control IgG (40 µg/10 g body weight) by intraperitoneal injection. Mice were euthanized 8 days after last antibody injection.
Statistics
Values are expressed as mean±SEM. P<0.05 was considered significant. Comparisons between 2 independent groups were performed using unpaired Student t tests with Welch correction. Comparisons between 2 independent cohorts (eg, wild type and CSILK-KO) at multiple time points were performed using 2-way ANOVA. Comparisons between 2 independent groups (eg, CSILK-KO mice with different antibody treatments) followed with repeated measures were performed using repeated-measures 2-way ANOVA. Bonferroni post hoc procedure was used in both cases. For DSAGE, statistical comparisons of gene expression were performed as previously described 25 using the Audic and Claverie alternative to Fisher exact test. 26 Kaplan-Meier curves were used to display survival data. The log-rank test was used to compare 2 survival curves.
Results
Cardiac-Specific Deletion of ILK
To investigate the role of ILK specifically in cardiomyocytes, we generated CSILK-KO by breeding α-MHC-Cre + transgenic mice 20 to ILK flox/flox mice. 21 Hearts from CSILK-KO mice had significantly reduced ILK expression at the mRNA and protein level ( Figure 1A and 1B) 10 days postnatally before the development of cardiac dysfunction. As previously reported by others, 21 ILK deletion significantly reduced baseline phosphorylation of Akt ( Figure 1B ). The residual ILK expression seen in whole ventricle extracts likely reflects expression in noncardiomyocytes. This was confirmed by immunofluorescence staining for ILK, which revealed no signal in cardiomyocytes from CSILK-KO hearts but preserved vascular expression ( Figure 1C ). Normal ILK expression was also seen in other tissues including brain, liver, lung, kidney, skeletal muscle, and intestine (data not shown). Thus, the conditional genetic strategy used produced effective and specific deletion of ILK in cardiomyocytes.
CSILK-KO Mice Exhibit Early Postnatal Mortality and Develop DCM
CSILK-KO mice were born at the expected Mendelian frequency (data not shown) and had no obvious phenotypic differences compared with littermate controls at 10 days, but by 15 days, CSILK-KO pups manifested cardiac dilation and dysfunction on echocardiography, which became severe by 21 days (Figure 2A ; Table) . Echocardiographic parameters were consistent with the development of a DCM, including enlarged left ventricular chamber sizes (LV end-diastolic dimension and LV end-systolic dimension) starting at 15 days. In addition, the interventricular septum and left ventricular posterior walls became progressively thinner in CSILK-KO hearts. These changes in cardiac dimensions were accompanied by a striking decline in cardiac function in CSILK-KO mice, with fractional shortening declining from 61.28±1.38 at 10 days to 8.91±2.12 (Table) .
CSILK-KO mice died by 3 to 6 weeks of age (n=12; Figure 2A ). The median survival for the CSILK-KO mice was 4 weeks, with few mice surviving to 6 weeks, whereas, as expected, all ILK flox/flox control mice survived during this period. Both heart and lung weights normalized to tibial length were increased compared with controls ( Figure 2B ), consistent with DCM and heart failure with pulmonary edema. Histopathology of 21-day-old CSILK-KO hearts confirmed right and left ventricular enlargement and wall thinning compared with controls ( Figure 2C ). Baseline cardiac function in heterozygous ILK-KO mice (ILK flox/wt , cre + ) was normal (data not shown). However, the decrease in cardiac ILK expression in these mice was modest, suggesting that there may be compensatory upregulation from the remaining allele. Thus, they do not provide a test of haploinsufficiency.
Increased Cardiomyocyte Death, Fibrosis, and Inflammation in CSILK-KO Hearts
DCM can be associated with myocyte cell death, fibrosis, and inflammation, and we examined CSILK-KO hearts for evidence of these processes from 10 to 21 days after birth. Analysis of confocal images revealed increased numbers of TUNEL-positive cardiomyocytes in both atria and ventricles of CSILK-KO hearts compared with the hearts of their littermate controls (ILK flox/flox ; Figure 3A and 3B). We also found evidence of increased fibrosis by Masson trichrome staining ( Figure 3C and 3D) and leukocyte infiltration by CD45 staining (Figure 3E and 3F) . In each case, the findings progressively increased during this time period. Interestingly, cardiomyocyte apoptosis was significantly increased at 10 days before CSILK-KO mice develop cardiac dysfunction ( Figure 3A and 3B ). Fibrosis showed a trend toward increasing in 10-and 15-day-old CSILK-KO hearts and Comparisons between WT and cardiac-specific integrin-linked kinase knockout (CSILK-KO) at each time point were performed using regular 2-way ANOVA with Bonferroni post hoc tests. FS indicates fractional shortening; IVSd, interventricular septum (end-diastolic); IVSs, interventricular septum (end-systolic); LVDd, LV end-diastolic dimension; LVDs, LV end-systolic dimension; LVPWd, LV posterior wall (end-diastolic); LVPWs, LV posterior wall (end-systolic); number, number of mice; and WT, wild type. *P<0.05. †P<0.01. ‡P<0.001. was significantly increased at 21 days ( Figure 3C and 3D ). Inflammatory cell infiltration was significantly increased by 15 days in CSILK-KO hearts ( Figure 3E and 3F 27 Evans blue staining of cardiomyocytes as an indicator of necrosis was also increased in CSILK-KO hearts ( Figure I in the Data Supplement).
Deep Sequence Analysis of Gene Expression
We used DSAGE, a novel nanotechnology that facilitates global transcriptional profiling, to compare gene expression in hearts from 10-day-old CSILK-KOs and littermate controls to identify changes that precede the development of cardiac dysfunction. Approximately 2×10 6 cDNA clones from each genotype (5 hearts for each) were sequenced, corresponding to 33 274 independent transcripts. A total of 93 differentially expressed transcripts were identified with a fold change >1.4 and P<0.001, thresholds previously shown to identify relevant effector pathways while minimizing false discovery. 16 The 1.4-fold number represents a practical limit below which QRT-PCR assessment of differences becomes technically challenging to the point where we would prioritize other candidates. Twenty-five transcripts identified by DSAGE were assessed by QRT-PCR, and 16 of these DSAGE candidates were confirmed at P<0.05 (Figure 4 ). In some cases, the failure to validate may reflect a lack of statistical power to detect modest differences by QRT-PCR with 5 samples in each group. The single most highly upregulated transcript on both the DSAGE and QRT-PCR was OPN, which was 47-fold up in 10-day-old CSILK-KO hearts by DSAGE (P=9.6×10 −45 ) and 54-fold up (P<0.04) by QRT-PCR.
OPN Expression Is Regulated by ILK but Not by AKT
OPN, also known as Spp1 or Eta-1, 28 is an inflammatory chemokine that induces leukocyte infiltration and increases in a variety of cardiovascular diseases, including hypertrophy, 29 heart failure, 18 and myocarditis. 17, 30 Interestingly, recent work demonstrates that cardiomyocyte expression of OPN is sufficient to induce DCM associated with inflammatory infiltrates, cardiomyocyte apoptosis, and fibrosis. 19 Thus, the dramatic upregulation of OPN could contribute to the phenotypes observed after ILK deletion.
To explore this possibility further, we examined the timing of OPN RNA and protein expression in more detail. As noted above, OPN RNA expression was dramatically increased in CSILK-KO hearts before they develop abnormalities and continued to increase at postnatal days 15 and 21, whereas expression in control littermates remained consistently low throughout this period ( Figure 5A ). OPN protein level also increased early, significantly so by 15 days and further increased by day 21 in CSILK-KO hearts ( Figure 5B ).
To examine whether ILK regulates OPN expression in cardiomyocytes, we used siRNA to knockdown ILK in rat neonatal cardiomyocytes. QRT-PCR and Western blotting demonstrated reduced ILK mRNA and protein expression, as well as increased OPN expression, after transfection with an ILK-specific siRNA (Figure 5C and 5D) . Thus, reduced ILK leads to increased OPN expression in isolated cardiomyocytes in the absence of heart failure or other phenotypes that might induce OPN indirectly.
To test whether the increased OPN seen in CSILK-KO hearts contributes to the development of heart failure, we treated CSILK-KO mice with neutralizing OPN antibodies. CSILK-KO mice were followed by echocardiography until their fractional shortening declined to ≈40% (generally 14-18 days old) and then were injected intraperitoneally with a neutralizing anti-mouse OPN polyclonal goat IgG or control goat IgG every other day. Echocardiograms performed before each injection demonstrate that injection of the OPN-specific antibody mitigates the functional decline in CSILK-KO mice ( Figure 6 ) in comparison with control IgG-injected animals. Not surprisingly given in vivo IgG injection across species, the improvement was only transient with a subsequent decline in function that paralleled control IgG-injected CSILK-KO mice. Nevertheless, these data support the hypothesis that the dramatically increased OPN expression seen in CSILK-KO mice contributes to cardiac dysfunction.
To determine whether loss of Akt1 activation contributes to the increased OPN expression seen after ILK deletion, we examined ventricles from Akt1 KO mice. 12 Of note, as reported by others, Akt1 KO mice have a different phenotype 12,13 compared with CSILK-KO, with essentially normal baseline cardiac function and no evidence of fibrosis, inflammation, or apoptosis at baseline, although they do worse than wild-type mice after stress. 31 Neither OPN mRNA nor protein expression was altered in 4-week-old Akt1 KO 12 (Figure 7) . Thus, it is unlikely that the marked increase in OPN expression seen in CSILK-KO hearts is because of reduced Akt1 activation.
Discussion
ILK is an adaptor and serine/threonine kinase that links integrins with intracellular cytoskeletal elements and kinase signaling cascades. ILK mutations are associated with human DCM, and previous work suggested a role for ILK in preserving cardiac cytoarchitecture and FAK/Akt signaling. 7 However, the mild baseline phenotypes seen with genetic deletion of FAK and Akt suggested other important contributors and prompted us to generate cardiac-specific ILK KO mice. We found that cardiomyocyte-specific ILK deletion led to a severe and lethal DCM phenotype, which was even more dramatic than that previously reported for MCK-Cre-driven deletion where the median age of death was 8 weeks 7 compared with 4 weeks in our cohort. The more severe phenotype observed may reflect differential timing and effectiveness of ILK deletion with αMHC-Cre and is consistent with the suggestion by White et al 7 that skeletal muscle deletion did not contribute to the DCM phenotype they observed.
We noted cardiac fibrosis in CSILK-KO hearts as previously reported but also found a significant increase in cardiomyocyte cell death that preceded the development of cardiac dysfunction or cytoarchitectural abnormalities, as well as early infiltration of inflammatory leukocytes, neither of which were previously noted. 7 The timing of these histological phenotypes suggested that they may play an early mechanistic role rather than simply being secondary consequences of disrupted cell-cell or cellmatrix interactions. 7 Although baseline Akt phosphorylation was also decreased early in CSILK-KO hearts, both Akt germline KOs and FAK cardiac KOs have essentially normal function at these ages, suggesting that other pathways play an important role.
To identify other contributors to these phenotypes, we performed genome-wide transcript profiling of 10-day-old hearts from CSILK-KOs and wild-type controls. We chose this time point because it precedes the development of cardiac dysfunction and thus would less likely be confounded by transcriptional effects of the altered phenotypes. Transcript profiling was performed using DSAGE, a recently developed approach that enables sequencing 10 6 to 10 7 tags at low cost with a ≈100-fold improvement in sensitivity and speed by using parallel rather than serial analyses. 16 In addition to the improved fidelity for low-abundance transcripts, the large number of independent clones sequenced using DSAGE provides more robust statistical comparisons. 16 DSAGE revealed differential expression of 93 transcripts. The single most upregulated transcript was OPN (Spp1), an inflammatory chemokine previously noted to increase in cardiac hypertrophy and heart failure. 18, 30 Multiple cell lineages present in the failing heart can express OPN. OPN has been identified in rat cardiac fibroblasts, where it contributes to angiotensin II-induced remodeling 32 ; in cardiomyocytes 33 ; and in macrophages with inflammation. 34 Graf et al 30 report that cardiomyocytes are a prominent source of OPN in vivo both in rat and in humans. PPARγ −/− (peroxisome proliferator-activated receptors) cardiomyocytes have increased OPN expression, which contribute to macrophage accumulation within the myocardium. 35 Furthermore, diabetes mellitus also increases OPN protein levels in the myocardium. 36 Whether there are distinct functional effects of OPN expressed by cardiomyocytes compared with fibroblasts is not clear, but it seems likely that the secreted signal recruits a similar target population of inflammatory cells in both cases. Cardiomyocyte-specific expression of OPN is sufficient to induce a lethal DCM associated with apoptosis, fibrosis, and inflammation 19 similar to that observed after ILK deletion although with a somewhat delayed onset. Interestingly, ongoing OPN expression was required for maintenance of the inflammation and lethal cardiomyopathy phenotype, 19 raising the possibility that inhibiting OPN could have a therapeutic benefit in some settings. Consistent with this hypothesis, treatment of CSILK-KO mice with a neutralizing antibody to OPN transiently shifted the decline in cardiac function. Unfortunately, the only neutralizing OPN antibody available is a goat polyclonal, so the transience of mitigation could reflect either immunologic clearance of the foreign antibody by the host or a contribution of OPNindependent factors to cardiac dysfunction.
OPN seems to have multiple effects that include modulating fibroblast and myocyte adhesion to the matrix, matrix synthesis, and synergism with other profibrotic molecules. 37 Two studies have demonstrated that OPN can induce MMP-2 (matrix metalloproteinase) and MMP-9 activation through a NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells)-dependent mechanism. 38, 39 We examined MMP activity by gelatin zymography in CSILK-KO hearts as well and found that MMP-2 activity was increased in mice with heart failure but not before the development of cardiac dysfunction ( Figure IIA and IIB in the Data Supplement). These data suggest that the increased MMP activity is unlikely to be a primary cause of the DCM phenotype in this model. ILK has been reported to regulate inflammation in tissuespecific ways. Loss of ILK from mouse hepatocytes results in acute hepatitis, with a variety of pathological findings including inflammation, fatty change, apoptosis, abnormal mitoses, and necrosis. 40 ILK knockdown impaired LPS-mediated endothelial activation by preventing the induction of ICAM-1 (intercellular adhesion molecule 1) and VCAM-1 (vascular cell adhesion molecule 1). 41 In contrast, ILK plays a proinflammatory role in intestinal inflammation through effects on chemokine expression, extracellular matrix, and immune tolerance. 42 Our results confirm previous findings with heart and skeletal muscle ILK deletion 7 but extend them in several important ways. First, the similar though more severe phenotype observed with cardiac-restricted deletion suggest (as postulated by White et al 7 ) that skeletal muscle deletion is not an important contributor to the DCM phenotype. Second, we document previously unreported phenotypes, including cardiomyocyte apoptosis, necrosis, and inflammation in hearts after ILK deletion. Finally, genome-wide transcript profiling identified marked upregulation of the inflammatory chemokine, OPN, early after ILK deletion and before the development of cardiac dysfunction or structural abnormalities. The other differentially regulated transcripts provide a comprehensive overview of ILK-dependent gene expression in the heart that should provide a helpful foundation for future investigation. Taken together, these results support a previously unrecognized connection between ILK and cardiac inflammation, mediated through regulation of OPN expression. We hypothesize that the rapidly lethal DCM observed after ILK deletion probably reflects the combined effects of OPN upregulation along with defective survival signaling and altered cytoskeletal interactions, accounting for the increased severity compared with that seen with genetic manipulation of individual components of these pathways.
The potential clinical relevance of these observations is underscored by the association of human ILK mutations with cardiomyopathy. 4 Whether inflammation contributes to the clinical presentation in these patients or might be targeted for intervention has not been established and warrants additional investigation. Because OPN is secreted, measuring serum levels in these patients would provide a practical next step in assessing the potential contribution of OPN.
